UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 58 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $99,000 | +15.1% | 16,486 | 0.0% | 0.00% | – |
Q4 2020 | $86,000 | +115.0% | 16,486 | +41.9% | 0.00% | – |
Q3 2020 | $40,000 | -60.4% | 11,620 | 0.0% | 0.00% | – |
Q2 2020 | $101,000 | +18.8% | 11,620 | -20.8% | 0.00% | – |
Q1 2020 | $85,000 | -19.8% | 14,678 | 0.0% | 0.00% | – |
Q4 2019 | $106,000 | +47.2% | 14,678 | +23.8% | 0.00% | – |
Q3 2019 | $72,000 | -36.3% | 11,853 | 0.0% | 0.00% | – |
Q2 2019 | $113,000 | +36.1% | 11,853 | +15.8% | 0.00% | – |
Q1 2019 | $83,000 | -50.0% | 10,237 | 0.0% | 0.00% | – |
Q4 2018 | $166,000 | – | 10,237 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Partner Investment Management, L.P. | 308,730 | $4,481,000 | 3.43% |
EcoR1 Capital, LLC | 967,114 | $15,754,000 | 1.42% |
NF Trinity Capital (Hong Kong) Ltd | 608,060 | $9,905,000 | 1.31% |
PFM Health Sciences, LP | 829,868 | $12,572,000 | 0.18% |
Baillie Gifford | 3,803,014 | $61,951,000 | 0.07% |
Artal Group S.A. | 50,000 | $815,000 | 0.02% |
AllSquare Wealth Management LLC | 556 | $9,000 | 0.01% |
FMR LLC | 3,562,723 | $56,232,000 | 0.01% |
Capital World Investors | 1,035,000 | $16,860,000 | 0.00% |
GILDER GAGNON HOWE & CO LLC | 20,000 | $326,000 | 0.00% |